======= MAP6D1 ======= == Gene Information == * **Official Symbol**: MAP6D1 * **Official Name**: MAP6 domain containing 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=79929|79929]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9H9H5|Q9H9H5]] * **Interactions**: [[https://thebiogrid.org/search.php?search=MAP6D1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MAP6D1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/610593|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: May have microtubule-stabilizing activity. {ECO:0000250}. |STOP| |N-terminal peptidyl-L-cysteine N-palmitoylation| |N-terminal protein palmitoylation| |N-terminal protein lipidation| |Golgi-associated vesicle| |negative regulation of microtubule depolymerization| |N-terminal protein amino acid modification| |regulation of microtubule depolymerization| |protein palmitoylation| |negative regulation of microtubule polymerization or depolymerization| |peptidyl-cysteine modification| |negative regulation of protein depolymerization| |cis-Golgi network| |negative regulation of protein complex disassembly| |regulation of microtubule polymerization or depolymerization| |regulation of protein depolymerization| |protein lipidation| |lipoprotein biosynthetic process| |regulation of protein complex disassembly| |lipoprotein metabolic process| |negative regulation of supramolecular fiber organization| |negative regulation of cytoskeleton organization| |cytoskeleton-dependent intracellular transport| |protein acylation| |regulation of microtubule cytoskeleton organization| |calmodulin binding| |regulation of microtubule-based process| |microtubule binding| |microtubule| |regulation of supramolecular fiber organization| |negative regulation of organelle organization| |microtubule cytoskeleton organization| |regulation of cytoskeleton organization| |microtubule-based process| |negative regulation of cellular component organization| |peptidyl-amino acid modification| |cytoskeleton organization| |regulation of organelle organization| |organonitrogen compound biosynthetic process| |intracellular transport| |cellular macromolecule biosynthetic process| |macromolecule biosynthetic process| |establishment of localization in cell| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp13|Chloramphenicol 20μM R00 exp13]]|-1.97| |[[:results:exp67|BVD-523 15μM R02 exp67]]|1.88| |[[:results:exp282|Fluvastatin 2.2μM R06 exp282]]|1.97| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 10626 * **Expression level (log2 read counts)**: 2.5 {{:chemogenomics:nalm6 dist.png?nolink |}}